COVID-19 in patients with acute lymphoblastic leukemia

COVID-19 in patients with acute lymphoblastic leukemia

Background. Patients with acute lymphoblastic leukemia (ALL) have been the most vulnerable group of patients at risk of severe and extremely severe COVID-19 throughout the coronavirus pandemic. Secondary immunodeficiency due to acute leukemia, as well as antitumor treatment, predisposes to the devel...

Full description

Saved in:

Bibliographic Details
Main Authors:	T. S. Chudnova, E. N. Misyurina, E. A. Baryakh, T. N. Tolstykh, L. T. Shimanovskaya, D. E. Gagloeva, E. I. Zhelnova, A. B. Makeshova, K. V. Yatskov, E. N. Zotina, D. D. Ivanova, M. A. Mingalimov, O. L. Kochneva, E. Yu. Grishina, V. N. Yakimets
Format:	Article
Language:	Russian
Published:	ABV-press 2024-09-01
Series:	Онкогематология
Subjects:	adult acute lymphoblastic leukemia coronavirus disease chemotherapy
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/953
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

COVID-19 in patients with acute leukemia: 3 years' experience of pandemic
by: T. S. Chudnova, et al.
Published: (2024-01-01)

Basic therapeutic approaches to the management of hematology/oncology patients with new coronavirus infection (COVID-19)
by: E. N. Misyurina, et al.
Published: (2024-01-01)

Treatment features of adult patients with acute myeloid leukemia during the COVID-19 pandemic
by: D. E. Gagloeva, et al.
Published: (2024-01-01)

Treatment experience of coronavirus infection associated with SARS-CoV-2 in patients with acute myeloid leukemia in the older age group
by: L. T. Shimanovskaya, et al.
Published: (2024-01-01)

Treatment of elderly patients with acute myeloid leukemia: personal experience
by: L. T. Shimanovskaya, et al.
Published: (2024-12-01)

Chronic lymphocytic leukemia in combination with COVID-19: clinical features and unfavorable prognosis factors
by: O. L. Kochneva, et al.
Published: (2024-01-01)

Prognostic model and risk factors for hospital mortality in patients with diffuse large B-cell lymphoma associated with coronavirus infection: a single-center cohort study
by: Yu. Yu. Polyakov, et al.
Published: (2024-01-01)

Clinical features and treatment strategy for patients with multiple myeloma during the COVID-19 pandemic
by: V. N. Yakimets, et al.
Published: (2024-01-01)

Coronavirus infection after blood stem cell transplantation
by: E. Yu. Grishina, et al.
Published: (2024-01-01)

Treatment efficiency in patients with acute myeloid leukemia from 2019 to 2023 according to the Moscow Cancer Registry
by: T. N. Tolstykh, et al.
Published: (2024-09-01)

Chemotherapy of hematological malignancies in patients with COVID-19
by: T. S. Chudnova, et al.
Published: (2022-04-01)

HETEROGENEITY OF CHILDHOOD B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (EGIL SUBTYPE BIV)
by: I. A. Demina, et al.
Published: (2018-02-01)

Results of external quality control study in flow cytometric acute lymphoblastic leukemia diagnostics
by: A. M. Popov, et al.
Published: (2016-10-01)

Clinical case of successful treatment of COVID-19 infection manifested with B-cell acute lymphoblastic leukemia
by: T. N. Aleksandrova, et al.
Published: (2022-01-01)

Comparative efficacy of acute lymphoblastic leukemia treatment of children in St.-Petersburg using two COALL-92 versions
by: E. G. Boychenko, et al.
Published: (2014-07-01)

Treatment outcomes for acute T-lymphoblastic leukemias/lymphomas: data from the ALL-2016 multicenter prospective randomized trial
by: O. A. Aleshina, et al.
Published: (2023-03-01)

Immunophenotypic investigation of infant acute lymphoblastic leukemia
by: A. M. Popov, et al.
Published: (2014-07-01)

Immunophenotypic features of bone marrow tumor cell in Burkitt lymphoma/leukemia: B-lineage acute lymphoblastic leukemia diagnostics opportunities
by: I. A. Demina, et al.
Published: (2017-04-01)

Hemostasis defects correction in children with acute lymphoblastic leukemia
by: A. S. Roshik, et al.
Published: (2022-11-01)

Comparative analysis of therapy results in children with acute lymphoblastic leukemia receiving ALL-MB-2002 and COALL-St.Petersburg-92 protocols
by: E. G. Boychenko, et al.
Published: (2022-11-01)

Features of children temperament with acute lymphoblastic leukemia
by: N. A. Kornetov, et al.
Published: (2016-02-01)

Surveillance and expected outcome of acute lymphoblastic leukemia in children and adolescents: An experience from Eastern India
by: Ashis Mukhopadhyay, et al.
Published: (2013-01-01)

Sinonasal diffuse large B-cell lymphoma: own clinical observation and literature review
by: M. A. Mingalimov, et al.
Published: (2024-04-01)

Prognostic factors of children’s acute lymphoblastic leukemia therapy in Moscow—Berlin protocols
by: J. V. Roumiantseva, et al.
Published: (2022-11-01)

Hepatic Dysfunction during Induction Chemotherapy in Children with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma and Its Effects on Subsequent Therapy and Outcome
by: Nalla Anuraag Reddy, et al.
Published: (2024-04-01)

Acute lymphoblastic leukemia with eosinophilia: diagnostic and treatment features
by: O. D. Gurieva, et al.
Published: (2025-05-01)

Optimization of native E. coli-asparaginase therapy in standard risk-group children with acute lymphoblastic leukemia treated by the ALL-MB 2002 protocol
by: M. Yu. Goroshkova, et al.
Published: (2022-11-01)

CREBBP is a Major Prognostic Biomarker for Relapse in Childhood B-cell Acute Lymphoblastic Leukemia: A National Study of Unselected Cohort
by: Krstevska Bozhinovikj E, et al.
Published: (2025-03-01)

Detection of 11q23 (MLL) rearrangements in infant acute lymphoblastic leukemia
by: G. A. Tsaur, et al.
Published: (2014-07-01)

Profile of acute lymphoblastic leukemia in children under 2 years of age
by: Anoop Cherungonath, et al.
Published: (2018-01-01)

Infant lymphoblastic leukemia: a single centers 10 year experience
by: İnci Yaman-Bajin, et al.
Published: (2019-06-01)

Native and pegylated forms of L-asparaginase: the assessment of effectiveness and toxicity in acute lymphoblastic leukemia treated with Berlin–Frankfurt–Munster (BFM) protocol
by: M. A. Shervashidze, et al.
Published: (2024-12-01)

Obesity in children with acute lymphoblastic leukemia in remission: the evaluation of causes, hidden nutritional deficiency and the experience of its correction by using artificial enteral nutrition
by: A. Yu. Vashura, et al.
Published: (2021-11-01)

RUSSIAN-BELARUSIAN MULTICENTER GROUP STANDARD GUIDELINES FOR CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA FLOW CYTOMETRIC DIAGNOSTICS
by: I. A. Novikova, et al.
Published: (2018-05-01)

Flow cytometric minimal residual disease monitoring in children with acute lymphoblastic leukemia treated by regimens with reduced intensity
by: A. M. Popov, et al.
Published: (2015-12-01)

Pharmacoeconomic analysis of treatment of children with acute lymphoblastic leukemia according to ALL-MB-2002 protocol
by: N. V. Miga, et al.
Published: (2022-11-01)

Radiation-induced hypopituitarism in children with acute lymphoblastic leukemia
by: Mehrdad Mirouliaei, et al.
Published: (2013-01-01)

Molecular genetic abnormalities in patients with T-cell acute lymphoblastic leukemia: a literature review
by: A. N. Vasileva, et al.
Published: (2022-11-01)

Significance of immunophenotypic, cytogenetic, and molecular markers in adult patients with T-cell lymphoblastic leukemia
by: A. N. Vasileva, et al.
Published: (2024-04-01)

Polymorphisms of the <i>TPMT</i>, <i>NUDT15</i> genes and 6-mercaptopurine toxicity profile in adult patients with Ph-negative acute lymphoblastic leukemia/lymphomas on the ALL-2016 protocol
by: E. S. Kotova, et al.
Published: (2022-07-01)